CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹25,774 Cr | ₹22,753 Cr | ₹21,763 Cr | ₹19,160 Cr | ₹17,132 Cr |
What is the latest Revenue of CIPLA ?
Year | Revenue |
---|---|
Mar2024 | ₹25,774 Cr |
Mar2023 | ₹22,753 Cr |
Mar2022 | ₹21,763 Cr |
Mar2021 | ₹19,160 Cr |
Mar2020 | ₹17,132 Cr |
How is Revenue of CIPLA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹25,774 Cr | 13.28 | |
Mar2023 | ₹22,753 Cr | 4.55 | |
Mar2022 | ₹21,763 Cr | 13.59 | |
Mar2021 | ₹19,160 Cr | 11.84 | |
Mar2020 | ₹17,132 Cr | - |
Compare Revenue of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹120,033.6 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
MANKIND PHARMA | ₹102,231.0 Cr | -2.1% | -0.6% | 33.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -0.9% |
-1.7% |
17.3% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses